X
20
Polymed Therapeutics, Inc. Houston Us, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Docetaxel, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2012-029 - Rev 01
This Chemical Type CEP, issued on March 25, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2593 associated with this CEP further emphasizes